Synergistic hepatoprotective effects of semaglutide and resmetirom combination therapy in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH

被引：0

作者：

Voldum-Clausen, Kristoffer ^{[1
]}

Norlin, Jenny Egecioglu ^{[2
]}

Veidal, Sanne Skovgard ^{[2
]}

Oro, Denise ^{[1
]}

Nilsson, Line ^{[1
]}

Hansen, Henrik B. ^{[1
]}

Feigh, Michael ^{[1
]}

机构：

[1] Gubra AS, Horsholm, Denmark

[2] Novo Nordisk, Malov, Denmark

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-244

引用

页码：S580 / S580

页数：1

共 50 条

[1] SYNERGISTIC HEPATOPROTECTIVE EFFECTS OF SEMAGLUTIDE AND RESMETIROM COMBINATION THERAPY IN THE GAN DIET- INDUCED OBESE AND BIOPSY- CONFIRMED MOUSE MODEL OF MASH
Nohr-Meldgaard, Jacob
Veidal, Sanne
Norlin, Jenny
Nilsson, Line Wendt
Hansen, Henrik
Feigh, Michael
Nielsen, Malte
HEPATOLOGY, 2024, 80 : S73 - S73
[2] Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Mollerhoj, Mathias B.
Veidal, Sanne S.
Thrane, Kirstine Tolbol
Oro, Denise
Overgaard, Agnete
Salinas, Casper Gravesen
Madsen, Martin Ronn
Pfisterer, Larissa
Vyberg, Mogens
Simon, Eric
Broermann, Andre
Vrang, Niels
Jelsing, Jacob
Feigh, Michael
Hansen, Henrik H.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (05): : 1167 - 1186
[3] Clinical translatability of the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Feigh, Michael
Andersen, Maja
Eskesen, Nicolas
Oro, Denise
Hansen, Henrik B.
JOURNAL OF HEPATOLOGY, 2024, 80 : S568 - S568
[4] HEPATOPROTECTIVE EFFECTS OF SEMAGLUTIDE IN THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NASH WITH ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA
Nielsen, Malte Hasle
Mollerhoj, Mathias Bonde
Oro, Denise
Madsen, Martin R.
Vyberg, Mogens
Hansen, Henrik H.
Feigh, Michael
HEPATOLOGY, 2022, 76 : S737 - S738
[5] HEPATOPROTECTIVE EFFECTS OF SEMAGLUTIDE IN THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NASH WITH ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA
Heimburger, Sebastian Moller Nguyen
Nielsen, Malte H.
Mollerhoj, Mathias Bonde
Oro, Denise
Madsen, Martin R.
Vyberg, Mogens
Hansen, Henrik H.
Feigh, Michael
GASTROENTEROLOGY, 2023, 164 (06) : S1262 - S1262
[6] Additive hepatoprotective effects of DA-1241, a novel GPR119 agonist, in combination with semaglutide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Lewinska, Monika
Nielsen, Malte H.
Pors, Susanne
Hansen, Henrik B.
Jung, Il Hoon
Kim, Hyung Heon
Feigh, Michael
Kim, Mi-Kyung
JOURNAL OF HEPATOLOGY, 2024, 80 : S576 - S576
[7] Differential hepatoprotective effects of semaglutide and lanifibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC
Nielsen, Malte H.
Pors, Susanne
Nohr-Meldgaard, Jacob
Madsen, Andreas Nygaard
Mollerhoj, Mathias Bonde
Oro, Denise
Vyberg, Mogens
Hansen, Henrik B.
Feigh, Michael
JOURNAL OF HEPATOLOGY, 2023, 78 : S530 - S531
[8] Semaglutide Reduces Tumor Burden in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of MASH with Advanced Fibrosis and HCC
Feigh, Michael
Tozzi, Marco
Hansen, Henrik H.
DIABETES, 2024, 73
[9] Preclinical efficacy and clinical translatability of resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Feigh, Michael
Nohr-Meldgaard, Jacob
Pors, Susanne
Hansen, Henrik B.
JOURNAL OF HEPATOLOGY, 2023, 78 : S800 - S800
[10] METABOLIC, BIOCHEMICAL AND HISTOPATHOLOGICAL EFFECTS OF LONG-TERM TREATMENT WITH SEMAGLUTIDE IN THE GAN DIET-INDUCED OBESE AND BIOPSY-CONFIRMED MOUSE MODEL OF NASH
Feigh, Michael
Thorbek, Ditte Denker
Madsen, Martin Ronn
Veidal, Sanne S.
Hansen, Henrik H.
HEPATOLOGY, 2021, 74 : 1145A - 1145A

← 1 2 3 4 5 →